Research paperImpact of steric bulk on photoinduced ligand exchange reactions in Mn(I) photoCORMs
Graphical abstract
Introduction
Carbon monoxide is a gaseous molecule that participates in several cell signaling pathways. As a result, endogenously produced CO plays important physiological roles such as anti-inflammation, cytoprotection, vasodilation, and blood vessel formation [1], [2], [3], [4], [5], [6]. Recent research has also indicated therapeutic potential for CO, such as anti-bacterial and anti-cancer activity [3], [5], [7], [8], [9], [10]. At high concentrations, CO is anti-proliferative and pro-apoptotic in cancer cells, while it is anti-apoptotic and anti-inflammatory in healthy tissue [3]. Due to the toxicity and storage safety issues arising from inhalation of gaseous CO [11], delivery of the small molecule with high spatiotemporal control is an important goal. The tendency of CO to act as a Lewis base, forming coordinate covalent (or dative) bonds with transition metal ions, has enabled the development of CO-releasing molecules (termed “CORMs”), in which the CO is deactivated through formation of metal-CO bond [12], [13], [14]. Upon bond cleavage, the CO is released and its pharmacological activity is restored.
CORMs that release CO through photochemical bond dissociation are known as “photoCORMs,” or photo-activated CO-releasing molecules [15], [16], [17], [18], [19], [20], [21]. PhotoCORMs allow for CO to remain coordinated to a metal complex pro-drug until irradiation with UV or visible light at a desired location, such as a tumor or infection, releases one or more equivalents of CO. The wavelength required for bond cleavage and the number of CO molecules released per metal complex depend on the molecular architecture. While many photoCORMs have been reported featuring Fe, Ru, Cr, W, Mo, and Re [2], [15], [22], [23], [24], [25], [26], [27], [28], [29], those featuring Mn(I) have been increasingly studied due to their ability to release multiple equivalents of CO with visible light [7], [8], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], a desirable feature to decrease photoinduced damage to healthy cells and tissue [53].
A frequently studied architecture for Mn(I) photoCORMs is fac-[Mn(NN)(CO)3(L)]n+, in which NN is typically a diimine bidentate ligand and L is a monodentate ancillary ligand such as Br−, CH3CN, phosphines, or N-containing heterocycles. The identities of NN and L influence the photophysical properties and photochemical ligand dissociation. Excitation with visible light results in population of a lowest-lying metal-to-ligand charge transfer (MLCT) state, which may also have a significant amount of halide-to-ligand charge transfer (XLCT) character if L is a halide [15], [19]. The reduced electron density on the metal weakens the π-backbonding between Mn and CO ligands, allowing ligand dissociation. It is generally reported that the quantum yield for CO release (ΦCO) increases as π-acidity of the bidentate ligand increases [15]. For example, in the set of fac-[Mn(NN)(CO)3Br] compounds in which NN = (2-phenyliminomethyl)quinoline (pimq), 2-quinoline-N-(2′-methylthiophenyl)methyleneimine (qmtpm), and 2-pyridyl-N-(2′-methylthiophenyl)methyleneimine (pmtpm), the value for ΦCO with 509 nm irradiation increases from NN = pimq to pmtpm to qmtpm as conjugation on the NN ligand increases [54].
The efficiency and rate of CO release are also influenced by the nature of the monodentate ancillary ligand L, as π-donor ligands tend to provide greater CO release efficiency compared to π-acceptor ligands. In the case of the fac-[Mn(qmtpm)(CO)3L]n+ and fac-[Mn(pmtpm)(CO)3L]n+ complexes, the CO release rate is greater when L = Br− compared to L = CH3CN [54]. The π-donor Br− destabilizes the Mn(dπ) orbitals relative to the case when L is the π-acceptor CH3CN, resulting in a lower energy MLCT state and enhanced absorptivity at longer wavelengths. Similarly, in photoCORMs with the fac-[Mn(azpy)(CO)3(L)]n+ (azpy = 2-phenylazopyridine) architecture, the rate of CO release from the compound when L = Br− is greater than the rate when L = PPh3 [33], [34]. Monodentate ligands that coordinate through imidazolyl groups also increase the quantum yield for CO dissociation compared to those with piperazinyl groups, as observed in the fac-[Mn(phen)(CO)3(L)]+ complexes, where phen = 1,10-phenanthroline and L = imidazoledanysl or 1-dansylpiperazine [39], [41].
Our previous work with fac-[Mn(NN)(CO)3Br] and fac-[Mn(NN)(CO)3(py)]+ photoCORMs, in which NN = 4,4′-dimethyl-2,2′-bipyridine (4,4′-Me2bpy), 2,2′-bipyridine (bpy), and 4,4′-dimethylester-2,2′-bipyridine (4,4′-dmebpy), highlighted the strong influence of the monodentate L ligand in the photochemical ligand dissociation reactions [47]. We discovered that a π-donating Br− directs photodissociation of an equatorial CO in the first step, while a π-accepting py directs photodissociation of the axial CO in the first step. We observed this trend regardless of the electron-donating (methyl) or electron-withdrawing (methyl ester) substituents at the 4,4′ positions of 2,2′-bipyridine. Additionally, in agreement with reports of related Mn(I) photoCORMs, the ΦCO increases with increasing NN π-acidity (4,4′-Me2bpy < bpy < 4,4′-dmebpy) in each series, and all compounds with L = Br− displayed larger ΦCO values than their L = py analogues.
The purpose of this work is to broaden our investigation by probing the impact of a sterically bulky NN bidentate ligand on the photochemical ligand dissociation efficiency and mechanism in fac-[Mn(NN)(CO)3L]n+ photoCORMs. The impact of steric distortion on fac-[Mn(NN)(CO)3L]n+ photoCORMs has not been clearly investigated. In this study, we utilized 6,6′-dimethyl-2,2′-bipyridine (6,6′-Me2bpy) to prepare two new photoCORMs, fac-[Mn(6,6′-Me2bpy)(CO)3Br] (6,6′-Me2bpy-Br) and fac-[Mn(6,6′-Me2bpy)(CO)3(py)]+ (6,6′-Me2bpy-py) for direct comparison to our previously reported fac-[Mn(4,4′-Me2bpy)(CO)3Br] (4,4′-Me2bpy-Br) and fac-[Mn(4,4′-Me2bpy)(CO)3(py)]+ (4,4′-Me2bpy-py) analogues [47]. The photoCORMs discussed in this work are shown in Fig. 1. The methyl groups at the 4,4′- and 6,6′-positions are expected to impart similar electronic effects but significantly different steric effects as a result of the placement of the substituents relative to the Mn-CO bonds. Herein we present an investigation into the impact of steric bulk on the structure and photophysical and photochemical properties of fac-[Mn(NN)(CO)3L]n+ photoCORMs.
Section snippets
Materials
Bromopentacarbonylmanganese(I) was purchased from Strem Chemicals. Silver trifluoromethanesulfonate (AgOTf) was purchased from Acros Organics. Acetonitrile, pyridine, dichloromethane, diethyl ether, methanol, hexane, and chloroform were purchased from Fisher Scientific. Potassium tris(oxalato)ferrate(III) was purchased from Alfa Aesar. Acetonitrile-d3 were purchased from Cambridge Isotope Laboratories. [Mn(4,4′-Me2bpy)3]ClO4 [55], fac-[Mn(4,4′-Me2bpy)(CO)3Br] (4,4′-Me2bpy-Br) [56], and fac
Synthesis and characterization
The new compounds 6,6′-Me2bpy-Br and 6,6′-Me2bpy-py were prepared by adapting the previously reported methods for the 4,4′-Me2bpy analogues [47], [56]. It is critical to keep all Mn(I)-containing solids and solutions in the dark, as rapid photodecomposition occurs under ambient light conditions. Elemental analysis (C, H, N, S) and ESI-MS were consistent with the proposed compositions, and the 1H NMR spectra in CD3CN (Figures S2 and S3) were consistent with the proposed structures.
Structural analysis
A comparison
Conclusions
Two new fac-[Mn(NN)(CO)3(L)]n+ photoCORMs, 6,6′-Me2bpy-Br and 6,6′-Me2bpy-py, featuring a sterically bulky bidentate ligand, were prepared, and their photophysical and photochemical properties were investigated compared to the previously reported 4,4′-Me2bpy analogues. While the placement of the methyl substituents has little impact on the electronic properties of the complexes, the steric distortion is apparent in the crystal structures of the four compounds. Notably, the steric bulk of the
CRediT authorship contribution statement
Shabnam Pordel: Conceptualization, Investigation, Visualization, Writing - original draft. Briana R. Schrage: Investigation, Visualization. Christopher J. Ziegler: Writing - review & editing, Supervision. Jessica K. White: Conceptualization, Investigation, Visualization, Supervision, Project administration, Writing - review & editing.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
We thank the Department of Chemistry and Biochemistry and the College of Arts and Sciences at Ohio University for start-up funds. We also acknowledge the Ohio Supercomputer Center for an allocation of computing time.
References (72)
- et al.
The social network of carbon monoxide in medicine
Trends Mol. Med.
(2013) - et al.
CO–metal interaction: vital signaling from a lethal gas
Trends Biochem. Sci.
(2006) - et al.
Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein
J. Inorg. Biochem.
(2019) - et al.
Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells
J. Biol. Chem.
(2004) - et al.
Carbon monoxide intoxication: an updated review
J. Neurol. Sci.
(2007) Metal complex strategies for photo-uncaging the small molecule bioregulators nitric oxide and carbon monoxide
Coord. Chem. Rev.
(2018)- et al.
Light-assisted and remote delivery of carbon monoxide to malignant cells and tissues: Photochemotherapy in the spotlight
J. Photochem. Photobiol., C
(2020) - et al.
Photochemically activated carbon monoxide release for biological targets.Toward developing air-stable photoCORMs labilized by visible light
Coordination Chem. Rev.
(2012) PhotoCORMs: Light-triggered release of carbon monoxide from the coordination sphere of transition metal complexes for biological applications
Inorg. Chim. Acta
(2011)- et al.
Differences in the CO photolability of cis- and trans-[RuCl2(azpy)(CO)2] complexes: Effect of metal-to-ligand back-bonding
Inorg. Chim. Acta
(2013)
Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1)
J. Inorg. Biochem.
The nature of the lowest excited state and photosubstitution reactivity of tetracarbonyl-1,10-phenanthrolinetungsten(0) and related complexes
J. Organomet. Chem.
Spectroscopic and electrochemical properties of [Mn(phen)(CO)3(imidazole)](SO3CF3) complexes
Inorg. Chim. Acta
Photo-induced eradication of human colorectal adenocarcinoma HT-29 cells by carbon monoxide (CO) delivery from a Mn-based green luminescent photoCORM
Inorg. Chim. Acta
Mechanistic aspects of the thermal mer-to-fac isomerization of mer-[Mn(X)(CO)3(α-diimine)] (X=Cl, Br, I)
J. Organomet. Chem.
Impact of Mn(I) photoCORM ligand set on photochemical intermediate formation during visible light-activated CO release
Inorg. Chim. Acta
Antibacterial and antiparasitic activity of manganese(I) tricarbonyl complexes with ketoconazole, miconazole, and clotrimazole ligands
Organometallics
Structure CO-releasing property, electrochemistry, DFT calculation, and antioxidant activity of benzimidazole derivative substituted [Mn(CO)3(bpy)L]PF6 type novel manganese complexes
Inorg. Chim. Acta
Further studies on the stabilization of high and low oxidation states in aromatic imine ligand complexes of first row transition metals. I. Substituted bipyridine complexes of cobalt and iron
Inorg. Chim. Acta
Experimental and theoretical characterisation of phosphorescence from rhenium polypyridyl tricarbonyl complexes
Polyhedron
Solvatochromism in substituted 2, 2′-bipyridinetetracarbonyl-metal complexes of chromium, molybdenum and tungsten
J. Organomet. Chem.
Emission property and DFT calculation for the 3MLCT luminescence of Ru(bpy)2(L)2+ complex
J. Mol. Struct.
Carbon monoxide–physiology, detection and controlled release
Chem. Commun.
Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities
Circ. Res.
The therapeutic potential of carbon monoxide
Nat. Rev. Drug Discovery
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications
Physiol. Rev.
Attenuation of antioxidant capacity in human breast cancer cells by carbon monoxide through inhibition of cystathionine β-synthase activity: implications in chemotherapeutic drug sensitivity
J. Med. Chem.
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth
Cancer Res.
Therapeutic applications of carbon monoxide-releasing molecules
Expert Opin. Invest. Drugs
Carbon-monoxide-releasing molecules for the delivery of therapeutic CO in vivo
Angew. Chem. Int. Ed.
Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs)
Br. J. Pharmacol.
Design strategies to improve the sensitivity of photoactive metal carbonyl complexes (photoCORMs) to visible light and their potential as CO-donors to biological targets
Acc. Chem. Res.
Photo-controlled release of NO and CO with inorganic and organometallic complexes
PhotoCORMs: CO release moves into the visible
Dalton Trans.
(Diimine)carbonyl complexes of chromium, molybdenum, and tungsten: relationship between resonance Raman spectra and photosubstitution quantum yields upon excitation within the lowest metal to diimine charge-transfer band
Inorg. Chem.
Photoactivity of mono- and dicarbonyl complexes of ruthenium(II) bearing an N, N, S-donor ligand: role of ancillary ligands on the capacity of CO photorelease
Inorg. Chem.
Cited by (8)
Solid-phase synthesis of peptides with azopyridine side-chains for Mn(i)-CO binding and red-light responsive CO release
2022, Inorganic Chemistry FrontiersPhotochemistry of transition metal complexes (2019-2020)
2022, PhotochemistrySyntheses and structure of dinuclear metal complexes containing naphthyl-Ir bichromophore
2021, Dalton Transactions